Nymox Pharmaceutical (NYMXF) Current Assets (2015 - 2025)
Nymox Pharmaceutical (NYMXF) posted Current Assets of $575,000 for Q4 2025, down 11.9% from $653,000 a year earlier.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Current Assets (2015 - 2025) Analysis & Trends
Since Q4 2015, Nymox Pharmaceutical has reported Current Assets for 30 quarters.
- Annual Current Assets shows a five-year compound annual growth rate of -31.8% (FY2020 to FY2025).
- In prior years, Nymox Pharmaceutical's Current Assets was $653,000 in FY2024 (+4.5%), $625,000 in FY2023 (-57.1%), $1.46 million in FY2022 (+40.5%) and $1.04 million in FY2021 (-73.4%).
- The Q4 2025 figure stands as the lowest quarterly Current Assets since Q2 2023.
- The strongest year-over-year quarter for Current Assets in the past five years was Q2 2021, with growth of 615.0%; the weakest was Q2 2023, with a decline of 94.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - | 575,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 575,000.00 |
| Dec 31, 2024 | 653,000.00 |
| Sep 30, 2024 | 623,000.00 |
| Dec 31, 2023 | 625,000.00 |
| Sep 30, 2023 | 654,000.00 |
| Jun 30, 2023 | 214,000.00 |
| Mar 31, 2023 | 461,000.00 |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 2.91 Mn |
| Jun 30, 2022 | 4.19 Mn |
| Mar 31, 2022 | 890,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 3.39 Mn |
| Jun 30, 2021 | 6.34 Mn |
| Mar 31, 2021 | 1.06 Mn |
| Dec 31, 2020 | 3.89 Mn |
| Sep 30, 2020 | 5.63 Mn |
| Jun 30, 2020 | 886,000.00 |
| Mar 31, 2020 | 3.13 Mn |
| Dec 31, 2019 | 5.33 Mn |
API Access
Nymox Pharmaceutical Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();